These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3111163)

  • 1. Single dose bromocriptine microcapsules in postpartum lactation inhibition.
    Svanberg L; Lancranjan I; Arvidsson T; Andersch B
    Acta Obstet Gynecol Scand; 1987; 66(1):61-2. PubMed ID: 3111163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactation inhibition by a single injection of a new depot-bromocriptine.
    Kremer JA; Rolland R; van der Heijden PF; Schellekens LA; Vosmar MB; Lancranjan I
    Br J Obstet Gynaecol; 1990 Jun; 97(6):527-32. PubMed ID: 2378830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical control during lactation inhibition with bromocriptine].
    Zubke W; Keller E; Göser R; Voge D; Schindler AE
    Arch Gynecol; 1979 Jul; 228(1-4):591-2. PubMed ID: 485492
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of LH/FSH releasing hormone (LRH) on the basal secretion of gonadotrophins in relation to plasma levels of oestradiol, progesterone and prolactin during the post-partum period in lactating and in non-lactating women.
    Jeppsson S; Rannevik G; Thorell JI; Wide L
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):713-28. PubMed ID: 322431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lactation by a long-acting bromocriptine.
    Peters F; Del Pozo E; Conti A; Breckwoldt M
    Obstet Gynecol; 1986 Jan; 67(1):82-5. PubMed ID: 3940343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prolactin in the restoration of ovarian function during the early post-partum period in the human female. II. A study during inhibition of lactation by bromergocryptine.
    Rolland R; de Jong FH; Schellekens LA; Lequin RM
    Clin Endocrinol (Oxf); 1975 Jan; 4(1):27-38. PubMed ID: 1122652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Return of gonadotropic function in postpartum women during bromocriptine treatment.
    Kremer JA; Rolland R; van der Heijden PF; Thomas CM; Lancranjan I
    Fertil Steril; 1989 Apr; 51(4):622-7. PubMed ID: 2494080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lactation by cyclofenil and bromocriptine.
    Thorbert G; Akerlund M
    Br J Obstet Gynaecol; 1983 Aug; 90(8):739-42. PubMed ID: 6411113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
    de Bernal M; de Villamizar M
    Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone.
    Kremer JA; Borm G; Schellekens LA; Thomas CM; Rolland R
    J Clin Endocrinol Metab; 1991 Feb; 72(2):294-300. PubMed ID: 1899421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of puerperal lactation by bromocriptine.
    Rolland R; Schellekens LA
    Acta Endocrinol Suppl (Copenh); 1978; 216():119-30. PubMed ID: 347857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of suckling on serum prolactin, luteinizing hormone, follicle-stimulating hormone, and estradiol during prolonged lactation.
    Battin DA; Marrs RP; Fleiss PM; Mishell DR
    Obstet Gynecol; 1985 Jun; 65(6):785-8. PubMed ID: 3923412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ; Josimovich JB; Archer DF
    Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of puerperal lactation. A double blind study of bromocriptine and placebo.
    Dewhurst CJ; Harrison RF; Biswas S
    Acta Obstet Gynecol Scand; 1977; 56(4):327-31. PubMed ID: 341635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of puerperal lactation with Parlodel long-acting (Parlodel LA).
    Rolland R; Nijdam W; Weyer A; Lancranjan I
    Eur J Obstet Gynecol Reprod Biol; 1986 Sep; 22(5-6):337-43. PubMed ID: 3770284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postpartum return of pituitary and ovarian activity during lactation inhibition with the new dopamine agonist CV 205-502 and during normal lactation.
    Kremer JA; van der Heijden PF; Schellekens LA; Thomas CM; Brownell J; Rolland R
    Acta Endocrinol (Copenh); 1990 Jun; 122(6):759-65. PubMed ID: 1973867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating hormonal levels during prolonged lactational amenorrhea.
    Dada OA; Laditan AA
    Clin Chim Acta; 1982 Aug; 123(3):287-92. PubMed ID: 6811163
    [No Abstract]   [Full Text] [Related]  

  • 18. The suppression of puerperal lactation with bromocryptine.
    Willmott MP; Colhoun EM; Bolton AE
    Acta Obstet Gynecol Scand; 1977; 56(2):145-9. PubMed ID: 324230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puerperal lactation suppression and prolactin.
    De Gezelle H; Dhont M; Thiery M; Parewyck W
    Acta Obstet Gynecol Scand; 1979; 58(5):469-72. PubMed ID: 394563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
    Van Dam LJ; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):323-30. PubMed ID: 7333409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.